Evidence map›Paper›PMID 35566101›Full record

ReviewMolecules (Basel, Switzerland)2022

Mohd Imran, Shah Alam Khan, Abida, Mohammed Kanan Alshammari, Saif M Alkhaldi, Fayez Nafea Alshammari, Mehnaz Kamal, Ozair Alam, Syed Mohammed Basheeruddin Asdaq, A Khuzaim Alzahrani and 1 more

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Current therapeutic research, clinical and experimental · 2024
    Article
  5. Review
  6. The effect ofFrontiers in pharmacology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mohd ImranDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Northern Border University, Rafha 91911, Saudi Arabia.ORCID 0000-0002-6064-1040
Shah Alam KhanDepartment of Pharmaceutical Chemistry, College of Pharmacy, National University of Science and Technology, Muscat 130, Oman.ORCID 0000-0002-0729-3403
AbidaDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Northern Border University, Rafha 91911, Saudi Arabia.ORCID 0000-0001-6186-461X
Mohammed Kanan AlshammariDepartment of Pharmaceutical Care, Rafha Central Hospital, Rafha 91911, Saudi Arabia.ORCID 0000-0001-6687-0461
Saif M AlkhaldiDepartment of Pharmaceutical Care, King Khalid Hospital in Majmaah, Riyadh 76312, Saudi Arabia.
Fayez Nafea AlshammariCommunity Pharmacist, Al-Dawaa Pharmacies, Hafer Albatin 39911, Saudi Arabia.
Mehnaz KamalDepartment of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.ORCID 0000-0002-3585-0828
Ozair AlamMedicinal Chemistry and Molecular Modelling Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.ORCID 0000-0003-0322-2509
Syed Mohammed Basheeruddin AsdaqDepartment of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Dariyah, Riyadh 13713, Saudi Arabia.ORCID 0000-0003-1533-9667
A Khuzaim AlzahraniDepartment of Medical Laboratory Technology, Faculty of Applied Medical Sciences, Northern Border University, Arar 91431, Saudi Arabia.
Shahamah JomahPharmacy Department, Sulaiman Al-Habib Medical Group, Riyadh 11643, Saudi Arabia.ORCID 0000-0002-9551-6434

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 has had an impact on human quality of life and economics. Scientists have been identifying remedies for its prevention and treatment from all possible sources, including plants.

Indexed as

COVID-19 Drug TreatmentNigella sativaPlants, MedicinalHumansInventionsQuality of LifeSARS-CoV-2black seedclinical trialCOVID-19inventionNigella sativa L.patentSARS-CoV-2

Identifiers

PMID35566101
PMCPMC9105261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.